查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1784172

全球皮下避孕植入市场

Subdermal Contraceptive Implants
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 281 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球皮下避孕植入物市场规模将达到 16 亿美元

全球皮下避孕植入市场规模预计在2024年达到11亿美元，预计在分析期内（2024-2030年）将以6.7%的复合年增长率增长，到2030年将达到16亿美元。依托孕烯植入是本报告分析的细分市场之一，预计其复合年增长率将达到7.9%，到分析期结束时达到11亿美元。levonorgestrel植入细分市场在分析期间的复合年增长率预计为4.6%。

美国市场规模估计为 2.96 亿美元，中国市场预计复合年增长率为 10.8%

美国皮下避孕植入物市场规模预计在2024年达到2.96亿美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到3.377亿美元，在2024-2030年的分析期内，复合年增长率为10.8%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为3.3%和6.6%。在欧洲，预计德国市场的复合年增长率为4.5%。

全球皮下避孕植入市场—主要趋势与驱动因素摘要

为什么皮下植入比传统避孕方法更受欢迎？

植入埋植避孕药在全球的快速普及，主要得益于育龄女性对长效可逆避孕药 (LARC) 的日益偏好。与每日口服避孕药或其他短期避孕方法（例如贴片和注射）不同，皮下植入只需一次植入即可提供三至五年的避孕效果，显着降低了使用者的错误操作风险，并提高了整体避孕效果。随着人们对生殖权利和避孕选择的认识和教育程度的提高，皮下埋植避孕药市场正在蓬勃发展，尤其是在医疗保健可近性不断提高的新兴市场。此外，世界卫生组织 (WHO)、联合国人口基金 (UNFPA) 和美国国际开发署(USAID) 等组织发起的公共卫生倡议，正在积极推动在高生育率和避孕资源匮乏的地区使用植入。与避孕器避孕器(IUD) 相比，皮下植入侵入性较小，且无需植入子宫，因此成为未生育女性的首选。植入维护成本低、隐蔽性强且可逆性强，正在改变人们对避孕的看法，使其更注重便利性、自主性和长期规划。因此，这些避孕设备不仅在受过良好教育的都市区中越来越受欢迎，而且透过政府和非政府组织支持的项目，也越来越多地覆盖农村和服务不足的地区。

医疗保健政策和国际宣传活动如何加速采用？

政府卫生政策和国际宣传活动在加速采用皮下避孕植入方面发挥了核心作用，特别是在计划生育需求未满足的地区。在中低收入国家 (LMIC)，在永续目标 (SDG) 等框架下实现全民生殖保健的努力刺激了避孕植入物的大规模采购和补贴分发。 FP2030伙伴关係和全球捐助联盟等倡议已经与製造商达成了优惠的价格协议，确保全球数百万女性能够负担得起或免费使用植入。各国政府，特别是撒哈拉以南非洲和东南亚的政府，正在将皮下植入纳入公共卫生计划，为社区卫生工作者提供培训，并扩大推广和信任。同时，在已开发国家，围绕女性健康、性别平等和生殖自主权的政策转变导致 LARC 被保险覆盖，并在青少年和年轻人中广泛采用。学校和诊所进行的宣传宣传活动，以及透过远端医疗和药房模式扩大服务可近性，正在确保更多人获得资讯和服务。这些协调一致的政策和倡议工作正在减少污名化，改善服务可近性，并赋能女性，使她们能够就自身生殖健康做出明智的选择。

技术创新是否改善了设备设计和接受度？

植入设计和插入方法的技术创新使其对医护人员和患者更具吸引力、更安全、更易于使用。市场正转向新一代植入，其桿更细、更灵活，更易于插入和取出，从而减少不适感。生物可吸收材料和荷尔蒙释放机制的进步使得活性药物（例如依托孕烯）的输送更加一致和可控，从而提高了疗效并减少了副作用。器械製造商也在开发智慧植入套件，以缩短手术时间和降低复杂性，这进一步鼓励医疗保健提供者提供此类选择。研究还着重于数位化或可追踪的植入包含微晶片或RFID（无线射频识别）标籤，用于储存给药资讯并方便患者追踪。此外，人们越来越重视具有文化敏感性的包装和说明材料，以提高其在不同社会文化背景下的接受度。由于在某些地区，取出仍然是一个问题，因此正在努力确保培训项目同样注重植入物插入和安全及时取出。所有这些技术进步都使设备更加以使用者为中心，从而提高患者满意度并扩大各个医疗生态系统的市场范围。

全球范围内植入需求不断增长的原因是什么？

皮下避孕植入物市场的成长受到多种因素的驱动，这些因素源于生殖健康趋势、医疗保健可近性、人口结构变化和医疗创新。全球对有效、低维护避孕措施的需求不断增长是一个主要驱动因素，尤其是对于那些寻求计划生育自主权而又不想面临每日坚持挑战的女性而言。都市区和农村的年轻一代对谨慎的长期避孕解决方案越来越感兴趣，而植入非常适合这一特点。在数据和教育宣传活动的支持下，人们越来越意识到延迟或间隔怀孕的健康和经济效益，这影响更多女性选择长效避孕方法。此外，政府和非政府组织支持的生殖健康计画的广泛采用，使更多社会经济群体更容易获得和负担得起这些植入。从医疗保健提供者的角度来看，与其他方法相比，植入目前越来越受欢迎，因为其给药方案简化、手术时间更短、后续需求更少。该装置本身的技术改进，包括更长的持续时间、更佳的激素输送以及更便捷的移除，正在提升消费者的信心。世界各地的监管机构也正在迅速核准和采用新的模式，以认识到其公共卫生价值。最后，人们对计划生育的文化态度的转变以及女性受教育和就业参与率的提高，强化了生殖自主权的重要性，使皮下植入成为现代避孕护理中一个引人注目的解决方案。

部分

产品（依托孕烯植入、levonorgestrel植入）、通路（医院、妇科诊所、社区健康中心、其他）

受访公司范例

  • Allergan plc
  • Baxter International Inc.
  • Bayer AG
  • Bayer Schering Pharma
  • Conceptus Inc.
  • Contraline, Inc.
  • DKT International
  • DKT WomanCare
  • Eli Lilly and Company
  • FHI 360
  • Gerresheimer AG
  • HRA Pharma
  • Karex Industries
  • KESSEL medintim GmbH
  • Leiras Oy
  • Mayer Laboratories
  • Merck & Co., Inc.
  • Novartis AG
  • Organon
  • Pfizer Inc.
  • Population Council
  • Reckitt Benckiser Group plc
  • Sandoz International GmbH
  • Schott AG
  • Shanghai Dahua Pharmaceutical Co., Ltd.
  • SMB Corporation
  • Teva Pharmaceutical Industries Ltd.
  • The Female Health Company
  • Theramex
  • Wyeth Pharmaceuticals

人工智慧集成

我们正在利用有效的专家内容和人工智慧工具来改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP33069

Global Subdermal Contraceptive Implants Market to Reach US$1.6 Billion by 2030

The global market for Subdermal Contraceptive Implants estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Etonogestrel Implant, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Levonorgestrel Implant segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$296.0 Million While China is Forecast to Grow at 10.8% CAGR

The Subdermal Contraceptive Implants market in the U.S. is estimated at US$296.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$337.7 Million by the year 2030 trailing a CAGR of 10.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Subdermal Contraceptive Implants Market - Key Trends & Drivers Summarized

Why Are Subdermal Implants Gaining Favor Over Traditional Contraceptives?

Subdermal contraceptive implants are witnessing a notable surge in global adoption, largely due to the growing preference for long-acting reversible contraceptives (LARCs) among women of reproductive age. Unlike daily oral contraceptives or short-term methods like patches and injections, subdermal implants offer protection for three to five years with a single insertion, significantly reducing the risk of user error and increasing overall efficacy. The market is benefitting from increased awareness and education about reproductive rights and contraception options, particularly in developing regions where access to healthcare is improving. Furthermore, public health initiatives by organizations such as the World Health Organization (WHO), UNFPA, and USAID are actively promoting the use of implants in regions with high fertility rates and limited access to contraceptive resources. Compared to intrauterine devices (IUDs), subdermal implants are less invasive and do not require uterine placement, making them a preferred option for women who may not have given birth. The minimal maintenance, discreet nature, and reversible function of implants are reshaping how contraception is viewed, shifting the narrative toward convenience, autonomy, and long-term planning. As a result, these devices are not only finding favor in urban, educated populations but also penetrating rural and underserved areas via government and NGO-supported programs.

How Are Healthcare Policies and Global Campaigns Accelerating Adoption?

Government healthcare policies and international campaigns are playing a central role in accelerating the adoption of subdermal contraceptive implants, especially in regions with unmet needs for family planning. In low- and middle-income countries (LMICs), the push toward universal access to reproductive healthcare under frameworks like the Sustainable Development Goals (SDGs) has spurred large-scale procurement and subsidized distribution of contraceptive implants. Initiatives such as the FP2030 partnership and global donor alliances have secured favorable pricing agreements with manufacturers, ensuring implants are affordable or free to millions of women worldwide. National governments, particularly in Sub-Saharan Africa and Southeast Asia, are integrating subdermal implants into public health programs and providing training for community health workers to increase outreach and trust. Meanwhile, in developed countries, policy shifts around women's health, gender equity, and reproductive autonomy have led to insurance coverage for LARCs, boosting their uptake among teenagers and young adults. School-based and clinic-based awareness campaigns, alongside expanding access via telehealth and pharmacy-based models, are ensuring that information and services reach broader populations. These coordinated policy and advocacy efforts are reducing stigma, improving access, and ensuring that women can make informed choices about their reproductive health-factors that are directly driving growth in the subdermal contraceptive implant market.

Are Technological Innovations Enhancing Device Design and Acceptance?

Yes, technological innovations in implant design and insertion methods are making subdermal contraceptive implants more appealing, safer, and easier to use for both healthcare providers and patients. The market is seeing a shift toward next-generation implants with thinner, more flexible rods that are easier to insert and remove with minimal discomfort. Advancements in bioresorbable materials and hormone release mechanisms are allowing for more consistent and controlled delivery of active agents like etonogestrel, thereby improving efficacy and reducing side effects. Device manufacturers are also developing smart insertion kits that reduce procedural time and complexity, further encouraging healthcare providers to offer the method. Some research efforts are focused on digital or trackable implants, incorporating microchips or radio-frequency identification (RFID) tags that can store dosing information and facilitate patient follow-up. Additionally, there’s an increased emphasis on culturally sensitive packaging and instruction materials, improving acceptance in diverse sociocultural contexts. As removal continues to be a concern in some regions, efforts are being made to ensure training programs focus equally on insertion and safe, timely removal. All these technological strides are making the devices more user-centric, thereby enhancing patient satisfaction and expanding market reach across different healthcare ecosystems.

What’s Behind the Rising Demand for These Implants Around the World?

The growth in the subdermal contraceptive implants market is driven by several factors rooted in reproductive health trends, healthcare access, demographic shifts, and medical innovation. The rising global demand for effective, low-maintenance contraception is a major driver, particularly among women seeking autonomy in family planning without daily adherence challenges. Younger populations in both urban and rural areas are showing increased interest in discreet, long-term contraceptive solutions, and implants fit that profile well. Growing awareness of the health and economic benefits of delayed or spaced pregnancies, supported by data and educational campaigns, is influencing more women to choose long-acting methods. Furthermore, the proliferation of government and NGO-supported reproductive health programs is making these implants more accessible and affordable across a wider range of socioeconomic groups. From a healthcare provider standpoint, implants are now favored due to simplified administration protocols, shorter procedure times, and fewer follow-up requirements compared to alternatives. Technological refinement in the devices themselves-such as longer duration, improved hormone delivery, and easier removability-is reinforcing consumer trust. Regulatory bodies worldwide are also fast-tracking approval and adoption of new models, recognizing their public health value. Lastly, shifting cultural attitudes toward family planning and increased female participation in education and the workforce are reinforcing the importance of reproductive autonomy, making subdermal implants a compelling solution in modern contraceptive care.

SCOPE OF STUDY:

The report analyzes the Subdermal Contraceptive Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Etonogestrel Implant, Levonorgestrel Implant); Distribution Channel (Hospital, Gynecology Clinics, Community Health Care Centers, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Allergan plc
  • Baxter International Inc.
  • Bayer AG
  • Bayer Schering Pharma
  • Conceptus Inc.
  • Contraline, Inc.
  • DKT International
  • DKT WomanCare
  • Eli Lilly and Company
  • FHI 360
  • Gerresheimer AG
  • HRA Pharma
  • Karex Industries
  • KESSEL medintim GmbH
  • Leiras Oy
  • Mayer Laboratories
  • Merck & Co., Inc.
  • Novartis AG
  • Organon
  • Pfizer Inc.
  • Population Council
  • Reckitt Benckiser Group plc
  • Sandoz International GmbH
  • Schott AG
  • Shanghai Dahua Pharmaceutical Co., Ltd.
  • SMB Corporation
  • Teva Pharmaceutical Industries Ltd.
  • The Female Health Company
  • Theramex
  • Wyeth Pharmaceuticals

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Subdermal Contraceptive Implants - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Focus on Long-Acting Reversible Contraceptives (LARCs) Propels Growth in Subdermal Implant Adoption
    • Increased Government and NGO-Led Family Planning Initiatives Expand the Addressable Market in Emerging Economies
    • Shift Toward Female-Centric and Autonomous Contraceptive Methods Strengthens the Business Case for Implants
    • Affordability and High Efficacy of Subdermal Implants Drive Demand in Public Health and Low-Income Settings
    • Growing Acceptance of Minimal-Maintenance Birth Control Solutions Accelerates Demand Across Age Groups
    • Technological Advancements in Implant Materials and Insertion Devices Spur Innovation and Safety Improvements
    • Healthcare Provider Training and Outreach Programs Drive Adoption in Underserved and Rural Populations
    • Changing Social Norms and Awareness Campaigns Generate Demand for Discreet and Long-Term Contraception
    • Rising Insurance Coverage and Reimbursement Support Strengthens Uptake in Developed Markets
    • Expanded Use in Postpartum and Adolescent Contraception Creates New Opportunities for Market Penetration
    • Demand for Reversible and Fertility-Preserving Options Spurs Preference for Implantable Devices
    • Integration of Contraceptive Counseling into Primary Healthcare Systems Supports Long-Term Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Subdermal Contraceptive Implants Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Subdermal Contraceptive Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Subdermal Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Etonogestrel Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Etonogestrel Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Etonogestrel Implant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Levonorgestrel Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Levonorgestrel Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Levonorgestrel Implant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Gynecology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Gynecology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Gynecology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Community Health Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Community Health Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Community Health Care Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • JAPAN
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • CHINA
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • EUROPE
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Subdermal Contraceptive Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Subdermal Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • FRANCE
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • GERMANY
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Subdermal Contraceptive Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Subdermal Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • INDIA
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Subdermal Contraceptive Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Subdermal Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Subdermal Contraceptive Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Subdermal Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • AFRICA
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030

IV. COMPETITION